Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04582396 · ClinicalTrials.gov registry record · NA
Stellate Ganglion Blockade to Reduce Cardiac Anxiety and PTSD Symptoms in Cardiac Arrest Survivors
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04582396 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 1 participants.
The verdict
NCT04582396, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a pilot randomized controlled trial (RCT) to gain preliminary evidence regarding the acceptability, tolerability, safety, and efficacy of a combined intervention of Stellate Ganglion Blockade (SGB) and psychoeducation on trauma symptoms and health behaviors in patients exhibiting early PTSD symptoms after cardiac arrest (CA). Primary Aim 1 (Feasibility outcomes): Gain preliminary evidence regarding the acceptability, tolerability, and safety of conducting a randomized trial that evaluates a single SGB treatment in conjunction with psychoeducation among CA patients with early PTSD symptoms. Secondary Aim 1 (Treatment-related outcomes): Test, whether SGB/psychoeducation treatment in CA patients with clinically significant PTSD symptoms is associated with reduced cardiac anxiety, PTSD symptoms, and improved health behaviors (physical activity and sleep duration), assessed objectively by a wrist-worn accelerometer for 4 weeks post-discharge.
Interventions
- BEHAVIORAL Psychoeducation
- PROCEDURE Normal saline injection
- PROCEDURE stellate ganglion block injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-03-11 |
| Est. Completion | 2021-04-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04582396
The ClinicalTrials.gov registry entry for NCT04582396 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Psychoeducation is the first listed.
NCT04582396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04582396 about?
NCT04582396 is a clinical study titled "Stellate Ganglion Blockade to Reduce Cardiac Anxiety and PTSD Symptoms in Cardiac Arrest Survivors". This is a pilot randomized controlled trial (RCT) to gain preliminary evidence regarding the acceptability, tolerability, safety, and efficacy of a combined intervention of Stellate Ganglion Blockade (SGB) and psychoeducation on trauma symptoms and health behaviors in patients exhibiting early PTSD ...
What is the current status of trial NCT04582396?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2021-03-11. Estimated completion is 2021-04-19.
What interventions are being tested in trial NCT04582396?
The interventions under investigation include: Psychoeducation (BEHAVIORAL), Normal saline injection (PROCEDURE), stellate ganglion block injection (PROCEDURE).
Who is sponsoring clinical trial NCT04582396?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.